A missing opportunity to alleviate suffering: the case of vulvar cancer
Salud Publica Mex. 2023 Dec 8;66(1, ene-feb):11-13. doi: 10.21149/15105.NO ABSTRACTPMID:38065109 | DOI:10.21149/15105 (Source: Salud Publica de Mexico)
Source: Salud Publica de Mexico - December 8, 2023 Category: Epidemiology Authors: Silvia Rosa Allende-P érez Emma L Ver ástegui Adriana Pe ña-Nieves Source Type: research
Survivorship research in advanced gynecological cancer: A scoping review of cohort studies
ConclusionOur findings highlight gaps in survivorship research for advanced gynecological cancers and emphasize the need for future studies to include and describe the experiences of diverse and underrepresented groups. (Source: Cancer Medicine)
Source: Cancer Medicine - November 27, 2023 Category: Cancer & Oncology Authors: Tracey DiSipio,
Emma Pearse,
Susan Jordan Tags: REVIEW Source Type: research
Cancers, Vol. 15, Pages 5581: Is There a Place for Brachytherapy in Vulvar Cancer? A Narrative Review
e
Jesús Romero
Vulvar cancer is a relatively rare neoplasm. The essential treatment is surgery for the primary tumour. However, postoperative recurrence rates are high, even in early-stage disease when tumour-free surgical margins are achieved or in the absence of associated risk factors (lymph node metastases, deep stromal invasion or invasion of the lymphatic vascular space). Radiotherapy plays an important role in the treatment of vulvar cancer. Adjuvant treatment after surgery as well as primary treatment of locally advanced vulvar cancer (LAVC) is composed of two key radiotherapy treatment scenarios, external b...
Source: Cancers - November 25, 2023 Category: Cancer & Oncology Authors: Sofia Cordoba Abel Cordoba Beatriz Gil Raquel Benlloch Silvia Rodriguez Dina Najjari-Jamal Sof ía Santana Lucie Bresson Cristina de la Fuente Jes ús Romero Tags: Review Source Type: research
Our Experience of Distal and Total Urethrectomies in Post Irradiated Vulvar Malignancies in Low Resource Settings: A Single Centre Study
ConclusionOur small group of patients represents a unique cohort of patients in whom surgery was attempted after radiation therapy. We have seen that surgery is a feasible option after radiotherapy in patients with advanced disease. (Source: The Journal of Obstetrics and Gynecology of India)
Source: The Journal of Obstetrics and Gynecology of India - November 16, 2023 Category: OBGYN Source Type: research
Incidence and survival of gynecologic cancer including cervical, uterine, ovarian, vaginal, vulvar cancer and gestational trophoblastic neoplasia in Korea, 1999-2019: Korea Central Cancer Registry
CONCLUSION: In Korea, the incidence of cervical cancer and GTN decreased, whereas the incidence of uterine, ovarian, and vulvar cancer increased from 1999 to 2019. The RSR for uterine, ovarian, and vulvar cancers showed consistent improvements over different periods. Effective screening programs and the adoption of advanced treatments may be necessary to further reduce the burden of gynecologic cancer.PMID:37953552 | DOI:10.5468/ogs.23208 (Source: Cancer Control)
Source: Cancer Control - November 13, 2023 Category: Cancer & Oncology Authors: Bo Seong Yun Eun Hye Park Johyun Ha Jung-Yun Lee Keun Ho Lee Taek Sang Lee Kyung Ju Lee Young Ju Kim Kyu-Won Jung Ju-Won Roh Source Type: research
Anxiety and depression among women with newly diagnosed vulvar cancer – A nationwide longitudinal study
ConclusionsWomen with newly diagnosed vulvar cancer report a high level of anxiety at diagnosis. Despite a significant improvement, anxiety remains widely prevalent during the first year of follow-up. Targeting insomnia, vulvar symptoms and unmet needs may decrease anxiety during surveillance. (Source: Acta Obstetricia et Gynecologica Scandinavica)
Source: Acta Obstetricia et Gynecologica Scandinavica - October 28, 2023 Category: OBGYN Authors: Diana Zach,
Pernille T. Jensen,
Henrik Falconer,
Zuzana Kolkova,
Katja Stenstr öm Bohlin,
Preben Kjølhede,
Elisabeth Åvall Lundqvist,
Angelique Flöter Rådestad Tags: ORIGINAL RESEARCH ARTICLE Source Type: research
10160 Sentinel Lymph Node Biopsy with Technetium-99m and Fluorescence Indocyanine Green for Vulvar Cancer
Effectiveness and safety of Indocyanine green (ICG) for sentinel lymph node biopsy on vulvar cancer. (Source: The Journal of Minimally Invasive Gynecology)
Source: The Journal of Minimally Invasive Gynecology - October 27, 2023 Category: OBGYN Authors: IC Bernal, E Yoon, MI Newman, J Cardenas Source Type: research
Factors associated with vulvar cancer from 2005 to 2021 in Togo, sub-Saharan Africa
vulvar cancer, once predominantly diagnosed in older women, is increasingly being diagnosed in younger individuals, due to Human Papillomavirus (HPV) infection. Our study aimed to describe the epidemiological ... (Source: BMC Women's Health)
Source: BMC Women's Health - September 26, 2023 Category: OBGYN Authors: Tchin Darr é, Bagassam Sama, Toukilnan Djiwa, Whitney E.D. Afantodji-Agbeti, Mayi Bombone, Yendoubé Kambote, Panakinao Simgban, Bingo K M’Bortche, Baguilane Douaguibe, Koffi Amégbor, Mazamaesso Tchaou, Abdoul-Samadou Aboubakari, Bayaki Saka and Gado Tags: Research Source Type: research
ERAS outcomes for vulvar oncological surgery in a high volume gynaecological oncological center
This study aims to evaluate ERAS implementation impact and evolution on ERAS vulvar oncologic surgical outcomes. (Source: Clinical Nutrition ESPEN)
Source: Clinical Nutrition ESPEN - September 21, 2023 Category: Nutrition Authors: Vanessa Samou ëlian, Audrey Feng-Émond, Laetitia Jourdan, Chantal Zaryczny, Elise de Castro Hillmann Source Type: research
Comorbidity in patients with Lichen sclerosus: a retrospective cohort study
This study confirmed the association between LS and vulvar cancer (OR = 17.4; 95% CI 12.1-25.3), penis cancer (OR = 9.1; 95% CI 4.3-18.9), prostate cancer (OR = 2.0; 95% CI 1.6-2.4) and breast cancer (OR = 1.6; 95% CI 1.4-1.8). LS was also associated with Crohn´s disease (OR = 2.0; 95% CI 1.6-2.6) and diabetes mellitus type 1 (OR = 1.9; 95% CI 1.6-2.1). The present study revealed novel important data regarding the association of LS with cancer and autoimmune diseases, emphasising the importance of sufficient treatment and follow-up of patients with LS. However, future studies are needed to confirm these results and the po...
Source: Cell Research - September 12, 2023 Category: Cytology Authors: Sandra Jerkovic Gulin Filippa Lundin Oliver Seifert Source Type: research
Definitive chemoradiation in vulvar squamous cell carcinoma: outcome and toxicity from an observational multicenter Italian study on vulvar cancer (OLDLADY 1.1)
CONCLUSION: In the context of CRT for LAVC, the present study reports encouraging results even if there is clearly room for further improvements, in terms of both treatment outcomes, toxicity and treatment interruption management.PMID:37700153 | DOI:10.1007/s11547-023-01712-8 (Source: Cancer Control)
Source: Cancer Control - September 12, 2023 Category: Cancer & Oncology Authors: Gabriella Macchia Valentina Lancellotta Martina Ferioli Calogero Cas à Donato Pezzulla Brigida Pappalardi Concetta Laliscia Edy Ippolito Jacopo Di Muzio Alessandra Huscher Francesca Tortoreto Mariangela Boccardi Roberta Lazzari Anna Myriam Perrone France Source Type: research
Definitive chemoradiation in vulvar squamous cell carcinoma: outcome and toxicity from an observational multicenter Italian study on vulvar cancer (OLDLADY 1.1)
ConclusionIn the context of CRT for LAVC, the present study reports encouraging results even if there is clearly room for further improvements, in terms of both treatment outcomes, toxicity and treatment interruption management. (Source: La Radiologia Medica)
Source: La Radiologia Medica - September 12, 2023 Category: Radiology Source Type: research
Comorbidity in patients with Lichen sclerosus: a retrospective cohort study
This study confirmed the association between LS and vulvar cancer (OR = 17.4; 95% CI 12.1–25.3), penis cancer (OR = 9.1; 95% CI 4.3–18.9), prostate cancer (OR = 2.0; 95% CI 1.6–2.4) and breast cancer (OR = 1.6; 95% CI 1.4–1.8). LS was also associated with Crohn´s disease (OR = 2.0; 95% CI 1.6–2.6) and diabetes mellitus type 1 (OR = 1.9; 95% CI 1.6–2.1). The present study revealed novel important data regarding the association of LS with cancer and autoimmune diseases, emphasising the importance of sufficient t reatment and follow-up of patients with LS. However, future studies are neede...
Source: European Journal of Medical Research - September 11, 2023 Category: Research Source Type: research
